BioCentury | Aug 29, 2011
Clinical News

Dermagraft: Development discontinued

...Inc. unit markets Dermagraft in the U.S. to treat full-thickness diabetic foot ulcers. Advanced BioHealing's TransCyte...
BioCentury | Aug 24, 2011
Clinical News

Shire discontinues Dermagraft for venous leg ulcers

...Inc. unit markets Dermagraft in the U.S. to treat full-thickness diabetic foot ulcers. Advanced BioHealing's TransCyte...
BioCentury | May 23, 2011
Finance

Strategic value trumps IPO

...submit a supplement to the existing PMA in 1Q12. Advanced BioHealing's other approved product is TransCyte...
BioCentury | May 6, 2011
Financial News

Advanced BioHealing sets IPO range

...fibroblast-derived skin substitute Dermagraft in the U.S. to treat full-thickness diabetic foot ulcers. The company's TransCyte...
BioCentury | Feb 28, 2011
Finance

Dermagraft redux

...1Q12. FDA denied approval for Dermagraft to treat venous leg ulcers in 2005. The company's TransCyte...
...1997, but has yet to be marketed. Advanced BioHealing hopes to create arrangements to market TransCyte...
...Advanced Tissue Sciences Inc. and partner Smith & Nephew plc (LSE:SN; NYSE:SNN) developed Dermagraft and TransCyte...
BioCentury | Feb 26, 2011
Financial News

Advanced BioHealing proposes IPO

...skin substitute Dermagraft in the U.S. to treat full-thickness diabetic foot ulcers. Another skin substitute, TransCyte...
BioCentury | Feb 28, 2007
Financial News

Advanced BioHealing raises $25.5 million

...BioHealing markets two human fibroblast-derived skin substitutes: Dermagraft to treat full-thickness diabetic foot ulcers and TransCyte...
BioCentury | Oct 8, 2001
Finance

Ebb & Flow

...it submitted the PMA in December 1996. The FDA approved the temporary covering version ( Dermagraft-TC...
BioCentury | Jul 6, 1999
Company News

Advanced Tissue, Smith & Nephew deal

...50-50 joint ventures focused on human-based tissue products, including Dermagraft for diabetic foot ulcers and TransCyte...
BioCentury | Mar 29, 1999
Clinical News

TransCyte: Marketed

...Researchers presented data from 38 patients showing that TransCyte reduced the length of hospital stay by...
...American Burn Association meeting in Orlando. Advanced Tissue Sciences Inc. (ATIS), La Jolla, Calif. Product: TransCyte...
Items per page:
1 - 10 of 45